Increased concentrations of Neurofilament Light Polypeptide (NLP) and neurogranin in the CSF and blood correlates with the degree of cognitive impairment and may be useful in the prognosis of the development of cognitive disorders in AD. Here, NRGN is linked to Alzheimer disease.